BAK1 Human (+)-dexrazoxane multiple interactions ISO Bak1 (Mus musculus) 6480464 [Doxorubicin co-treated with Dexrazoxane] results in decreased expression of BAK1 mRNA CTD PMID:26873546 BAK1 Human (+)-Tetrandrine increases expression EXP 6480464 tetrandrine results in increased expression of BAK1 protein CTD PMID:26822499 BAK1 Human (-)-citrinin multiple interactions EXP 6480464 [Citrinin co-treated with ochratoxin A] results in decreased expression of BAK1 mRNA CTD PMID:30428381 BAK1 Human (-)-citrinin increases expression EXP 6480464 Citrinin results in increased expression of BAK1 mRNA CTD PMID:30428381 BAK1 Human (-)-epigallocatechin 3-gallate decreases expression EXP 6480464 epigallocatechin gallate results in decreased expression of BAK1 mRNA CTD PMID:18851785 BAK1 Human (1->4)-beta-D-glucan multiple interactions ISO Bak1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of BAK1 mRNA CTD PMID:36331819 BAK1 Human (S)-(-)-perillyl alcohol increases expression EXP 6480464 perillyl alcohol results in increased expression of BAK1 protein CTD PMID:12530055 BAK1 Human (S)-amphetamine increases expression EXP 6480464 Dextroamphetamine results in increased expression of BAK1 protein CTD PMID:23820845 BAK1 Human (S)-amphetamine multiple interactions EXP 6480464 [N-Methyl-3 and 4-methylenedioxyamphetamine co-treated with Methamphetamine co-treated with 4-methylthioamphetamine co-treated with Dextroamphetamine] results in increased expression of BAK1 protein CTD PMID:23820845 BAK1 Human (S)-naringenin increases expression EXP 6480464 naringenin results in increased expression of BAK1 protein CTD PMID:27838343 BAK1 Human 1,1-dichloroethene increases expression ISO Bak1 (Mus musculus) 6480464 vinylidene chloride results in increased expression of BAK1 mRNA CTD PMID:26682919 BAK1 Human 1,2-dimethylhydrazine decreases expression ISO Bak1 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of BAK1 mRNA CTD PMID:22206623 BAK1 Human 1,2-dimethylhydrazine multiple interactions ISO Bak1 (Mus musculus) 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of BAK1 mRNA] CTD PMID:22206623 BAK1 Human 1,3-dinitrobenzene increases expression ISO Bak1 (Rattus norvegicus) 6480464 3-dinitrobenzene results in increased expression of BAK1 mRNA CTD PMID:24140754 BAK1 Human 17alpha-ethynylestradiol increases expression ISO Bak1 (Rattus norvegicus) 6480464 Ethinyl Estradiol results in increased expression of BAK1 mRNA CTD PMID:17557909 BAK1 Human 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of BAK1 mRNA CTD PMID:23373633 BAK1 Human 17beta-estradiol increases expression ISO Bak1 (Rattus norvegicus) 6480464 Estradiol results in increased expression of BAK1 mRNA CTD PMID:32145629 BAK1 Human 1H-pyrazole multiple interactions ISO Bak1 (Rattus norvegicus) 6480464 [Ethanol co-treated with pyrazole co-treated with Carbon Tetrachloride] results in increased expression of BAK1 mRNA CTD PMID:16610055 BAK1 Human 2,2',4,4',5,5'-hexachlorobiphenyl decreases expression EXP 6480464 2 more ... CTD PMID:20638727 BAK1 Human 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:27589474 BAK1 Human 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO Bak1 (Mus musculus) 6480464 2 more ... CTD PMID:38407484 BAK1 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Bak1 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of BAK1 mRNA CTD PMID:19520675 BAK1 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Bak1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of BAK1 mRNA CTD PMID:21570461 BAK1 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Bak1 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of BAK1 mRNA CTD PMID:22298810 BAK1 Human 2,4,6-trinitrobenzenesulfonic acid multiple interactions ISO Bak1 (Rattus norvegicus) 6480464 Losartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BAK1 mRNA] CTD PMID:15502641 BAK1 Human 2,4,6-trinitrobenzenesulfonic acid increases expression ISO Bak1 (Rattus norvegicus) 6480464 Trinitrobenzenesulfonic Acid results in increased expression of BAK1 mRNA CTD PMID:15502641 BAK1 Human 2-methoxy-17beta-estradiol increases expression ISO Bak1 (Mus musculus) 6480464 2-Methoxyestradiol results in increased expression of BAK1 protein CTD PMID:36414027 BAK1 Human 3,3',5,5'-tetrabromobisphenol A increases expression ISO Bak1 (Mus musculus) 6480464 tetrabromobisphenol A results in increased expression of BAK1 protein CTD PMID:27592553 BAK1 Human 3,4-methylenedioxymethamphetamine multiple interactions EXP 6480464 [N-Methyl-3 and 4-methylenedioxyamphetamine co-treated with Methamphetamine co-treated with 4-methylthioamphetamine co-treated with Dextroamphetamine] results in increased expression of BAK1 protein CTD PMID:23820845 BAK1 Human 3,4-methylenedioxymethamphetamine increases expression EXP 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of BAK1 protein CTD PMID:23820845 BAK1 Human 4,4'-diaminodiphenylmethane increases expression ISO Bak1 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of BAK1 mRNA CTD PMID:18648102 BAK1 Human 4,4'-sulfonyldiphenol decreases methylation ISO Bak1 (Mus musculus) 6480464 bisphenol S results in decreased methylation of BAK1 exon CTD PMID:33297965 BAK1 Human 4,4'-sulfonyldiphenol decreases expression EXP 6480464 bisphenol S results in decreased expression of BAK1 protein CTD PMID:31945527 BAK1 Human 4,4'-sulfonyldiphenol increases methylation ISO Bak1 (Mus musculus) 6480464 bisphenol S results in increased methylation of BAK1 promoter CTD PMID:33297965 BAK1 Human 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of BAK1 protein CTD PMID:17273769 BAK1 Human 4-octylphenol increases expression ISO Bak1 (Mus musculus) 6480464 4-octylphenol results in increased expression of BAK1 mRNA CTD PMID:31345089 BAK1 Human 5-aza-2'-deoxycytidine increases expression EXP 6480464 Decitabine results in increased expression of BAK1 mRNA CTD PMID:17908484 BAK1 Human 5-azacytidine multiple interactions ISO Bak1 (Rattus norvegicus) 6480464 [Azacitidine co-treated with entinostat] results in increased expression of BAK1 mRNA CTD PMID:21224363 BAK1 Human 5-azacytidine increases expression ISO Bak1 (Rattus norvegicus) 6480464 Azacitidine results in increased expression of BAK1 mRNA CTD PMID:21224363 BAK1 Human 5-fluorouracil increases expression EXP 6480464 Fluorouracil results in increased expression of BAK1 more ... CTD PMID:15489892 more ... BAK1 Human 5-fluorouracil multiple interactions EXP 6480464 mithramycin A inhibits the reaction [Fluorouracil results in increased expression of BAK1 protein] CTD PMID:15489892 BAK1 Human 5-fluorouracil increases response to substance EXP 6480464 BAK1 mRNA results in increased susceptibility to Fluorouracil CTD PMID:18593893 BAK1 Human acetamide increases expression ISO Bak1 (Rattus norvegicus) 6480464 acetamide results in increased expression of BAK1 mRNA CTD PMID:31881176 BAK1 Human acetochlor increases expression EXP 6480464 acetochlor results in increased expression of BAK1 protein CTD PMID:25291404 BAK1 Human acetylsalicylic acid increases expression EXP 6480464 Aspirin results in increased expression of BAK1 protein CTD PMID:11532860 BAK1 Human actinomycin D multiple interactions ISO Bak1 (Rattus norvegicus) 6480464 Dactinomycin inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of BAK1 mRNA] CTD PMID:21281706 BAK1 Human actinomycin D multiple interactions ISO Bak1 (Mus musculus) 6480464 Dactinomycin promotes the reaction [BAK1 protein binds to BAK1 protein] CTD PMID:26670606 BAK1 Human aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of BAK1 mRNA CTD PMID:22100608 BAK1 Human alantolactone increases expression EXP 6480464 alantolactone results in increased expression of BAK1 protein CTD PMID:22721982 BAK1 Human aldehydo-D-glucose multiple interactions ISO Bak1 (Rattus norvegicus) 6480464 [[Oxygen deficiency co-treated with Glucose deficiency] results in increased susceptibility to Carvedilol] which results in decreased expression of BAK1 mRNA CTD PMID:29122578 BAK1 Human aldehydo-D-glucose multiple interactions EXP 6480464 [Glucose co-treated with Deferoxamine] results in increased expression of BAK1 mRNA and Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BAK1 mRNA] CTD PMID:33962019 BAK1 Human aldehydo-D-glucose increases expression ISO Bak1 (Rattus norvegicus) 6480464 Glucose results in increased expression of BAK1 mRNA CTD PMID:38444079 BAK1 Human all-trans-retinoic acid multiple interactions EXP 6480464 [Melatonin co-treated with Tretinoin] results in increased expression of BAK1 protein CTD PMID:10965999 BAK1 Human all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of BAK1 mRNA CTD PMID:23724009 BAK1 Human all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of BAK1 mRNA and Tretinoin results in increased expression of BAK1 protein CTD PMID:15498508 more ... BAK1 Human ammonium chloride affects expression ISO Bak1 (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of BAK1 mRNA CTD PMID:16483693 BAK1 Human anthocyanin multiple interactions ISO Bak1 (Rattus norvegicus) 6480464 Anthocyanins inhibits the reaction [Streptozocin results in increased expression of BAK1 protein] CTD PMID:28856781 BAK1 Human anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [docetaxel results in increased activity of BAK1 protein] CTD PMID:17317842 BAK1 Human antirheumatic drug decreases expression EXP 6480464 Antirheumatic Agents results in decreased expression of BAK1 mRNA CTD PMID:24449571 BAK1 Human arecoline increases expression ISO Bak1 (Rattus norvegicus) 6480464 Arecoline results in increased expression of BAK1 protein CTD PMID:33929070 BAK1 Human aristolochic acid A increases expression EXP 6480464 aristolochic acid I results in increased expression of BAK1 mRNA CTD PMID:33212167 BAK1 Human arsenite(3-) increases activity EXP 6480464 arsenite results in increased activity of BAK1 protein CTD PMID:17553788 BAK1 Human arsenite(3-) increases expression ISO Bak1 (Mus musculus) 6480464 arsenite results in increased expression of BAK1 mRNA CTD PMID:33053406 BAK1 Human arsenous acid multiple interactions EXP 6480464 [Arsenic Trioxide co-treated with Ascorbic Acid co-treated with Disulfiram] results in decreased expression of BAK1 protein CTD PMID:24126434 BAK1 Human arsenous acid multiple interactions ISO Bak1 (Mus musculus) 6480464 Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of BAK1 mRNA] more ... CTD PMID:21533816 and PMID:28587418 BAK1 Human arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of BAK1 mRNA CTD PMID:11940349 and PMID:17530438 BAK1 Human arsenous acid affects response to substance ISO Bak1 (Mus musculus) 6480464 BAK1 protein affects the susceptibility to Arsenic Trioxide CTD PMID:15979664 BAK1 Human arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of BAK1 protein CTD PMID:19695276 more ... BAK1 Human arsenous acid increases expression ISO Bak1 (Mus musculus) 6480464 Arsenic Trioxide results in increased expression of BAK1 mRNA CTD PMID:21533816 BAK1 Human arsenous acid decreases expression ISO Bak1 (Rattus norvegicus) 6480464 Arsenic Trioxide results in decreased expression of BAK1 mRNA CTD PMID:19730151 BAK1 Human atorvastatin calcium increases expression EXP 6480464 Atorvastatin results in increased expression of BAK1 protein CTD PMID:19935899 BAK1 Human auranofin multiple interactions ISO Bak1 (Mus musculus) 6480464 [BAX co-treated with BAK1] results in increased susceptibility to Auranofin and BAK1 mutant form inhibits the reaction [Auranofin results in increased activity of CASP3 protein] CTD PMID:18789312 and PMID:21172426 BAK1 Human auranofin increases response to substance ISO Bak1 (Mus musculus) 6480464 BAK1 results in increased susceptibility to Auranofin CTD PMID:18789312 BAK1 Human benzo[a]pyrene decreases methylation EXP 6480464 Benzo(a)pyrene results in decreased methylation of BAK1 promoter CTD PMID:27901495 BAK1 Human benzo[a]pyrene diol epoxide I multiple interactions ISO Bak1 (Mus musculus) 6480464 7 more ... CTD PMID:24837741 BAK1 Human benzo[a]pyrene diol epoxide I increases expression ISO Bak1 (Mus musculus) 6480464 7 more ... CTD PMID:24837741 BAK1 Human benzo[a]pyrene diol epoxide I affects response to substance ISO Bak1 (Mus musculus) 6480464 BAK1 protein affects the susceptibility to 7 more ... CTD PMID:24837741 BAK1 Human beta-D-glucan decreases expression EXP 6480464 beta-Glucans results in decreased expression of BAK1 mRNA CTD PMID:25970150 BAK1 Human betulinic acid increases expression EXP 6480464 Betulinic Acid results in increased expression of BAK1 protein CTD PMID:33181113 BAK1 Human betulinic acid multiple interactions EXP 6480464 [Betulinic Acid co-treated with Oxygen deficiency] results in increased expression of BAK1 protein CTD PMID:33181113 BAK1 Human bis(2-ethylhexyl) phthalate increases expression ISO Bak1 (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of BAK1 protein CTD PMID:36583613 BAK1 Human bis(2-ethylhexyl) phthalate multiple interactions ISO Bak1 (Mus musculus) 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of BAK1 mRNA and Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of BAK1 protein] CTD PMID:36583613 and PMID:37364641 BAK1 Human bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of BAK1 protein CTD PMID:21277958 BAK1 Human bisphenol A multiple interactions ISO Bak1 (Mus musculus) 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of BAK1 mRNA CTD PMID:37364641 BAK1 Human bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of BAK1 protein CTD PMID:33039870 and PMID:35439536 BAK1 Human bisphenol A multiple interactions EXP 6480464 [[ginger extract results in increased abundance of Oils more ... CTD PMID:33376534 and PMID:35439536 BAK1 Human bisphenol A decreases expression ISO Bak1 (Mus musculus) 6480464 bisphenol A results in decreased expression of BAK1 mRNA CTD PMID:33221593 BAK1 Human bisphenol A decreases expression ISO Bak1 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of BAK1 mRNA CTD PMID:30816183 more ... BAK1 Human bisphenol A increases expression ISO Bak1 (Mus musculus) 6480464 bisphenol A results in increased expression of BAK1 mRNA CTD PMID:31453682 BAK1 Human bisphenol A increases expression ISO Bak1 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of BAK1 mRNA CTD PMID:25181051 more ... BAK1 Human bisphenol F increases expression ISO Bak1 (Mus musculus) 6480464 bisphenol F results in increased expression of BAK1 mRNA CTD PMID:31453682 BAK1 Human bortezomib multiple interactions EXP 6480464 [nutlin 3 co-treated with Bortezomib] results in increased activity of BAK1 protein and BAK1 affects the reaction [Bortezomib results in increased susceptibility to and results in increased activity of TNFSF10 protein] CTD PMID:17326159 and PMID:20850924 BAK1 Human bortezomib multiple interactions ISO Bak1 (Mus musculus) 6480464 BAK1 protein results in increased susceptibility to [Bortezomib co-treated with TNFSF10 protein] CTD PMID:12902978 BAK1 Human bortezomib increases expression EXP 6480464 Bortezomib results in increased expression of BAK1 protein CTD PMID:17326159 BAK1 Human Brusatol increases expression EXP 6480464 brusatol results in increased expression of BAK1 protein CTD PMID:33465425 BAK1 Human butanal increases expression EXP 6480464 butyraldehyde results in increased expression of BAK1 mRNA CTD PMID:26079696 BAK1 Human Butylbenzyl phthalate multiple interactions ISO Bak1 (Mus musculus) 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of BAK1 mRNA CTD PMID:37364641 BAK1 Human cadmium atom multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Cadmium results in increased expression of BAK1] CTD PMID:23339468 BAK1 Human cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of BAK1 CTD PMID:23339468 BAK1 Human cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of BAK1 mRNA CTD PMID:38568856 BAK1 Human cadmium sulfide decreases expression EXP 6480464 cadmium sulfide results in decreased expression of BAK1 mRNA CTD PMID:27866839 BAK1 Human camptothecin decreases expression EXP 6480464 Camptothecin results in decreased expression of BAK1 mRNA CTD PMID:30581319 BAK1 Human camptothecin multiple interactions EXP 6480464 Folic Acid inhibits the reaction [Camptothecin results in decreased expression of BAK1 mRNA] CTD PMID:30581319 BAK1 Human capsaicin increases activity ISO Bak1 (Mus musculus) 6480464 Capsaicin results in increased activity of BAK1 protein CTD PMID:17295509 BAK1 Human capsaicin increases expression EXP 6480464 Capsaicin results in increased expression of BAK1 mRNA CTD PMID:19502594 BAK1 Human carbon nanotube increases expression ISO Bak1 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 BAK1 Human carbon nanotube increases expression EXP 6480464 Nanotubes and Carbon results in increased expression of BAK1 mRNA CTD PMID:15585362 BAK1 Human carvedilol multiple interactions ISO Bak1 (Rattus norvegicus) 6480464 [[Oxygen deficiency co-treated with Glucose deficiency] results in increased susceptibility to Carvedilol] which results in decreased expression of BAK1 mRNA CTD PMID:29122578 BAK1 Human casticin increases expression EXP 6480464 casticin results in increased expression of BAK1 protein CTD PMID:27862857 BAK1 Human cefaloridine increases expression ISO Bak1 (Rattus norvegicus) 6480464 Cephaloridine results in increased expression of BAK1 mRNA CTD PMID:18500788 BAK1 Human celecoxib increases expression EXP 6480464 Celecoxib analog results in increased expression of BAK1 protein more ... CTD PMID:19428934 and PMID:19682443 BAK1 Human celecoxib decreases response to substance ISO Bak1 (Rattus norvegicus) 6480464 BAK1 results in decreased susceptibility to Celecoxib CTD PMID:18349538 BAK1 Human CGP 52608 multiple interactions EXP 6480464 CGP 52608 promotes the reaction [RORA protein binds to BAK1 gene] CTD PMID:28238834 BAK1 Human chlorpyrifos increases expression ISO Bak1 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of BAK1 mRNA CTD PMID:37019170 BAK1 Human chrysophanol increases expression EXP 6480464 chrysophanic acid results in increased expression of BAK1 protein CTD PMID:30300626 BAK1 Human cisplatin multiple interactions ISO Bak1 (Mus musculus) 6480464 [BAX co-treated with BAK1] results in increased susceptibility to Cisplatin and [SLC39A8 protein results in increased susceptibility to Cisplatin] which results in increased expression of BAK1 protein CTD PMID:21172426 and PMID:30342059 BAK1 Human cisplatin increases cleavage EXP 6480464 Cisplatin results in increased cleavage of BAK1 protein CTD PMID:35525317 BAK1 Human cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of BAK1 mRNA and Cisplatin results in increased expression of BAK1 protein CTD PMID:11099651 more ... BAK1 Human cisplatin increases response to substance EXP 6480464 BAK1 protein results in increased susceptibility to Cisplatin CTD PMID:17688235 BAK1 Human cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with fisetin] results in increased expression of BAK1 protein more ... CTD PMID:21052098 more ... BAK1 Human coenzyme Q10 multiple interactions ISO Bak1 (Rattus norvegicus) 6480464 coenzyme Q10 inhibits the reaction [Doxorubicin results in increased expression of BAK1 protein] CTD PMID:27087047 BAK1 Human copper atom multiple interactions ISO Bak1 (Rattus norvegicus) 6480464 [Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased expression of BAK1 mRNA more ... CTD PMID:22085843 BAK1 Human copper(0) multiple interactions ISO Bak1 (Rattus norvegicus) 6480464 [Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased expression of BAK1 mRNA more ... CTD PMID:22085843 BAK1 Human coumarin increases expression EXP 6480464 coumarin analog results in increased expression of BAK1 protein CTD PMID:31199928 BAK1 Human cucurbitacin B increases expression EXP 6480464 cucurbitacin B results in increased expression of BAK1 mRNA and cucurbitacin B results in increased expression of BAK1 protein CTD PMID:26183715 BAK1 Human cucurbitacin B multiple interactions EXP 6480464 [cucurbitacin B co-treated with Gefitinib] results in increased expression of BAK1 mRNA and [cucurbitacin B co-treated with Gefitinib] results in increased expression of BAK1 protein CTD PMID:26183715 BAK1 Human curcumin multiple interactions EXP 6480464 TNFSF10 protein promotes the reaction [Curcumin results in increased expression of BAK1 protein] CTD PMID:18226269 BAK1 Human curcumin decreases expression EXP 6480464 Curcumin results in decreased expression of BAK1 mRNA CTD PMID:33582110 BAK1 Human curcumin increases expression EXP 6480464 Curcumin results in increased expression of BAK1 mRNA and Curcumin results in increased expression of BAK1 protein CTD PMID:17332930 and PMID:18226269 BAK1 Human curcumin increases response to substance ISO Bak1 (Mus musculus) 6480464 BAK1 protein results in increased susceptibility to Curcumin CTD PMID:17277231 BAK1 Human curcumin increases expression ISO Bak1 (Mus musculus) 6480464 Curcumin results in increased expression of BAK1 protein CTD PMID:17277231 BAK1 Human cylindrospermopsin increases expression EXP 6480464 cylindrospermopsin results in increased expression of BAK1 mRNA CTD PMID:23726867 BAK1 Human D-glucose multiple interactions ISO Bak1 (Rattus norvegicus) 6480464 [[Oxygen deficiency co-treated with Glucose deficiency] results in increased susceptibility to Carvedilol] which results in decreased expression of BAK1 mRNA CTD PMID:29122578 BAK1 Human D-glucose increases expression ISO Bak1 (Rattus norvegicus) 6480464 Glucose results in increased expression of BAK1 mRNA CTD PMID:38444079 BAK1 Human D-glucose multiple interactions EXP 6480464 [Glucose co-treated with Deferoxamine] results in increased expression of BAK1 mRNA and Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BAK1 mRNA] CTD PMID:33962019 BAK1 Human DDE multiple interactions ISO Bak1 (Rattus norvegicus) 6480464 Dactinomycin inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of BAK1 mRNA] CTD PMID:21281706 BAK1 Human DDE increases expression ISO Bak1 (Rattus norvegicus) 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of BAK1 mRNA CTD PMID:21281706 and PMID:21384494 BAK1 Human deguelin increases expression EXP 6480464 deguelin results in increased expression of BAK1 protein CTD PMID:26592500 BAK1 Human delphinidin increases expression EXP 6480464 delphinidin results in increased expression of BAK1 protein CTD PMID:29451351 BAK1 Human demethoxycurcumin decreases expression EXP 6480464 demethoxycurcumin results in decreased expression of BAK1 mRNA CTD PMID:33582110 BAK1 Human deoxynivalenol increases expression EXP 6480464 deoxynivalenol results in increased expression of BAK1 mRNA CTD PMID:20702593 BAK1 Human desferrioxamine B multiple interactions EXP 6480464 [Glucose co-treated with Deferoxamine] results in increased expression of BAK1 mRNA and Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BAK1 mRNA] CTD PMID:33962019 BAK1 Human Destruxin B increases expression EXP 6480464 destruxin B results in increased expression of BAK1 protein CTD PMID:24434019 BAK1 Human Destruxin B multiple interactions EXP 6480464 Sorafenib promotes the reaction [destruxin B results in increased expression of BAK1 protein] CTD PMID:24434019 BAK1 Human dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of BAK1 mRNA and Dexamethasone results in increased expression of BAK1 protein CTD PMID:19428934 BAK1 Human dexamethasone multiple interactions ISO Bak1 (Rattus norvegicus) 6480464 fludarabine inhibits the reaction [Dexamethasone results in increased expression of BAK1 protein] CTD PMID:30506661 BAK1 Human dexamethasone increases expression ISO Bak1 (Rattus norvegicus) 6480464 Dexamethasone results in increased expression of BAK1 protein CTD PMID:30506661 BAK1 Human Di-n-octyl phthalate multiple interactions ISO Bak1 (Mus musculus) 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of BAK1 mRNA CTD PMID:37364641 BAK1 Human diallyl trisulfide increases expression EXP 6480464 diallyl trisulfide results in increased expression of BAK1 protein CTD PMID:17513609 BAK1 Human diallyl trisulfide multiple interactions EXP 6480464 SOD2 protein inhibits the reaction [diallyl trisulfide results in increased activity of BAK1 protein] CTD PMID:23412769 BAK1 Human diallyl trisulfide increases activity EXP 6480464 diallyl trisulfide results in increased activity of BAK1 protein CTD PMID:23412769 BAK1 Human diarsenic trioxide affects response to substance ISO Bak1 (Mus musculus) 6480464 BAK1 protein affects the susceptibility to Arsenic Trioxide CTD PMID:15979664 BAK1 Human diarsenic trioxide increases expression ISO Bak1 (Mus musculus) 6480464 Arsenic Trioxide results in increased expression of BAK1 mRNA CTD PMID:21533816 BAK1 Human diarsenic trioxide multiple interactions ISO Bak1 (Mus musculus) 6480464 Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of BAK1 mRNA] more ... CTD PMID:21533816 and PMID:28587418 BAK1 Human diarsenic trioxide decreases expression ISO Bak1 (Rattus norvegicus) 6480464 Arsenic Trioxide results in decreased expression of BAK1 mRNA CTD PMID:19730151 BAK1 Human diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of BAK1 protein CTD PMID:19695276 more ... BAK1 Human diarsenic trioxide multiple interactions EXP 6480464 [Arsenic Trioxide co-treated with Ascorbic Acid co-treated with Disulfiram] results in decreased expression of BAK1 protein CTD PMID:24126434 BAK1 Human diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of BAK1 mRNA CTD PMID:11940349 and PMID:17530438 BAK1 Human diazinon affects expression ISO Bak1 (Rattus norvegicus) 6480464 Diazinon affects the expression of BAK1 mRNA CTD PMID:22546817 BAK1 Human Dibutyl phosphate affects expression EXP 6480464 di-n-butylphosphoric acid affects the expression of BAK1 mRNA CTD PMID:37042841 BAK1 Human dibutyl phthalate multiple interactions ISO Bak1 (Mus musculus) 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of BAK1 mRNA CTD PMID:37364641 BAK1 Human diclofenac increases activity EXP 6480464 Diclofenac results in increased activity of BAK1 protein CTD PMID:18191430 BAK1 Human dieldrin affects expression ISO Bak1 (Rattus norvegicus) 6480464 Dieldrin affects the expression of BAK1 mRNA CTD PMID:22546817 BAK1 Human diepoxybutane increases expression EXP 6480464 diepoxybutane results in increased expression of BAK1 and diepoxybutane results in increased expression of BAK1 mRNA CTD PMID:17693053 and PMID:29792945 BAK1 Human diethyl phthalate multiple interactions ISO Bak1 (Mus musculus) 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of BAK1 mRNA CTD PMID:37364641 BAK1 Human Diisodecyl phthalate multiple interactions ISO Bak1 (Mus musculus) 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of BAK1 mRNA CTD PMID:37364641 BAK1 Human diisononyl phthalate multiple interactions ISO Bak1 (Mus musculus) 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in increased expression of BAK1 mRNA CTD PMID:37364641 BAK1 Human Dimethyl phthalate increases expression ISO Bak1 (Rattus norvegicus) 6480464 dimethyl phthalate results in increased expression of BAK1 mRNA CTD PMID:35598668 BAK1 Human dioscin multiple interactions ISO Bak1 (Mus musculus) 6480464 dioscin inhibits the reaction [Acetaminophen results in increased expression of BAK1 protein] CTD PMID:22939915 BAK1 Human dioscin increases expression EXP 6480464 dioscin results in increased expression of BAK1 mRNA and dioscin results in increased expression of BAK1 protein CTD PMID:22334414 more ... BAK1 Human dioxygen multiple interactions ISO Bak1 (Rattus norvegicus) 6480464 [[Oxygen deficiency co-treated with Glucose deficiency] results in increased susceptibility to Carvedilol] which results in decreased expression of BAK1 mRNA CTD PMID:29122578 BAK1 Human dioxygen multiple interactions EXP 6480464 [Betulinic Acid co-treated with Oxygen deficiency] results in increased expression of BAK1 protein CTD PMID:33181113 BAK1 Human disodium selenite increases expression EXP 6480464 Sodium Selenite results in increased expression of BAK1 mRNA CTD PMID:16705456 BAK1 Human disulfiram multiple interactions EXP 6480464 [arsenic trioxide co-treated with Ascorbic Acid co-treated with Disulfiram] results in decreased expression of BAK1 protein CTD PMID:24126434 BAK1 Human doxorubicin decreases response to substance EXP 6480464 BAK1 protein results in decreased susceptibility to Doxorubicin CTD PMID:11313874 BAK1 Human doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of BAK1 mRNA CTD PMID:30581319 BAK1 Human doxorubicin increases expression ISO Bak1 (Rattus norvegicus) 6480464 Doxorubicin results in increased expression of BAK1 mRNA and Doxorubicin results in increased expression of BAK1 protein CTD PMID:27087047 more ... BAK1 Human doxorubicin multiple interactions ISO Bak1 (Rattus norvegicus) 6480464 coenzyme Q10 inhibits the reaction [Doxorubicin results in increased expression of BAK1 protein] CTD PMID:27087047 BAK1 Human doxorubicin increases expression ISO Bak1 (Mus musculus) 6480464 Doxorubicin results in increased expression of BAK1 mRNA and Doxorubicin results in increased expression of BAK1 protein CTD PMID:26873546 and PMID:34713381 BAK1 Human doxorubicin multiple interactions ISO Bak1 (Mus musculus) 6480464 [Doxorubicin co-treated with Dexrazoxane] results in decreased expression of BAK1 mRNA CTD PMID:26873546 BAK1 Human doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of BAK1 mRNA and Doxorubicin results in increased expression of BAK1 protein CTD PMID:20856197 and PMID:29803840 BAK1 Human doxorubicin increases response to substance EXP 6480464 BAK1 protein results in increased susceptibility to Doxorubicin CTD PMID:17688235 BAK1 Human doxorubicin increases activity EXP 6480464 Doxorubicin results in increased activity of BAK1 protein CTD PMID:15917298 BAK1 Human doxorubicin multiple interactions EXP 6480464 BAK1 protein results in increased susceptibility to [Doxorubicin co-treated with PI103] more ... CTD PMID:15917298 more ... BAK1 Human entinostat multiple interactions ISO Bak1 (Rattus norvegicus) 6480464 [Azacitidine co-treated with entinostat] results in increased expression of BAK1 mRNA CTD PMID:21224363 BAK1 Human entinostat increases expression ISO Bak1 (Mus musculus) 6480464 entinostat results in increased expression of BAK1 protein CTD PMID:21041383 BAK1 Human epichlorohydrin increases expression EXP 6480464 Epichlorohydrin results in increased expression of BAK1 mRNA CTD PMID:29792945 BAK1 Human esculetin increases expression EXP 6480464 esculetin results in increased expression of BAK1 protein CTD PMID:26388407 BAK1 Human ethanol multiple interactions ISO Bak1 (Rattus norvegicus) 6480464 [Ethanol co-treated with pyrazole co-treated with Carbon Tetrachloride] results in increased expression of BAK1 mRNA CTD PMID:16610055 BAK1 Human ethanol increases expression ISO Bak1 (Mus musculus) 6480464 Ethanol results in increased expression of BAK1 protein CTD PMID:27270636 BAK1 Human ethanol multiple interactions ISO Bak1 (Mus musculus) 6480464 SIAH1 protein promotes the reaction [Ethanol results in increased expression of BAK1 protein] CTD PMID:27270636 BAK1 Human ethyl methanesulfonate increases expression EXP 6480464 Ethyl Methanesulfonate results in increased expression of BAK1 mRNA CTD PMID:23649840 BAK1 Human etoposide increases activity EXP 6480464 Etoposide results in increased activity of BAK1 protein CTD PMID:21745461 BAK1 Human etoposide increases response to substance EXP 6480464 BAK1 protein results in increased susceptibility to Etoposide CTD PMID:17688235 BAK1 Human etoposide affects response to substance ISO Bak1 (Mus musculus) 6480464 BAK1 protein affects the susceptibility to Etoposide CTD PMID:16077961 BAK1 Human etoposide multiple interactions EXP 6480464 nimesulide inhibits the reaction [Etoposide results in increased activity of BAK1 protein] CTD PMID:21745461 BAK1 Human etoposide affects expression EXP 6480464 Etoposide affects the expression of BAK1 protein CTD PMID:15215046 BAK1 Human farnesol increases expression EXP 6480464 Farnesol results in increased expression of BAK1 protein CTD PMID:12530055 BAK1 Human farrerol increases expression EXP 6480464 farrerol results in increased expression of BAK1 mRNA and farrerol results in increased expression of BAK1 protein CTD PMID:35833306 BAK1 Human fisetin multiple interactions EXP 6480464 [Cisplatin co-treated with fisetin] results in increased expression of BAK1 protein CTD PMID:21216935 BAK1 Human flavonoids multiple interactions ISO Bak1 (Mus musculus) 6480464 Flavonoids inhibits the reaction [Carbon Tetrachloride results in increased expression of BAK1 protein] CTD PMID:23279844 BAK1 Human flufenamic acid multiple interactions EXP 6480464 Flufenamic Acid inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAK1 protein] CTD PMID:27957685 BAK1 Human flufenoxuron increases expression ISO Bak1 (Mus musculus) 6480464 flufenoxuron results in increased expression of BAK1 protein CTD PMID:33771252 BAK1 Human folic acid multiple interactions EXP 6480464 Folic Acid inhibits the reaction [Camptothecin results in decreased expression of BAK1 mRNA] more ... CTD PMID:30581319 BAK1 Human folic acid multiple interactions ISO Bak1 (Mus musculus) 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of BAK1 mRNA] CTD PMID:22206623 BAK1 Human fonofos increases methylation EXP 6480464 Fonofos results in increased methylation of BAK1 promoter CTD PMID:22847954 BAK1 Human fructose increases expression ISO Bak1 (Rattus norvegicus) 6480464 Fructose results in increased expression of BAK1 protein CTD PMID:33475235 BAK1 Human fructose multiple interactions ISO Bak1 (Rattus norvegicus) 6480464 Plant Extracts inhibits the reaction [Fructose results in increased expression of BAK1 protein] CTD PMID:33475235 BAK1 Human fulvestrant multiple interactions EXP 6480464 Fulvestrant inhibits the reaction [bisphenol A results in increased expression of BAK1 protein] CTD PMID:35439536 BAK1 Human furan increases expression ISO Bak1 (Rattus norvegicus) 6480464 furan results in increased expression of BAK1 mRNA CTD PMID:22079235 and PMID:26194646 BAK1 Human furosemide affects expression ISO Bak1 (Rattus norvegicus) 6480464 Furosemide affects the expression of BAK1 mRNA CTD PMID:17497460 BAK1 Human gefitinib multiple interactions EXP 6480464 [cucurbitacin B co-treated with Gefitinib] results in increased expression of BAK1 mRNA and [cucurbitacin B co-treated with Gefitinib] results in increased expression of BAK1 protein CTD PMID:26183715 BAK1 Human genistein multiple interactions EXP 6480464 [ASRGL1 protein co-treated with Genistein] results in increased expression of BAK1 protein CTD PMID:33347704 BAK1 Human genistein increases expression EXP 6480464 Genistein results in increased expression of BAK1 protein CTD PMID:33347704 BAK1 Human geraniol increases expression EXP 6480464 geraniol results in increased expression of BAK1 protein CTD PMID:12530055 BAK1 Human glucose multiple interactions ISO Bak1 (Rattus norvegicus) 6480464 [[Oxygen deficiency co-treated with Glucose deficiency] results in increased susceptibility to Carvedilol] which results in decreased expression of BAK1 mRNA CTD PMID:29122578 BAK1 Human glucose increases expression ISO Bak1 (Rattus norvegicus) 6480464 Glucose results in increased expression of BAK1 mRNA CTD PMID:38444079 BAK1 Human glucose multiple interactions EXP 6480464 [Glucose co-treated with Deferoxamine] results in increased expression of BAK1 mRNA and Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BAK1 mRNA] CTD PMID:33962019 BAK1 Human gold atom increases expression EXP 6480464 Gold results in increased expression of BAK1 mRNA CTD PMID:22178767 BAK1 Human gold(0) increases expression EXP 6480464 Gold results in increased expression of BAK1 mRNA CTD PMID:22178767 BAK1 Human hydrogen peroxide increases expression ISO Bak1 (Rattus norvegicus) 6480464 Hydrogen Peroxide results in increased expression of BAK1 protein CTD PMID:14505808 BAK1 Human hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of BAK1 mRNA CTD PMID:12419474 BAK1 Human hydrogen peroxide multiple interactions ISO Bak1 (Rattus norvegicus) 6480464 Quercetin inhibits the reaction [Hydrogen Peroxide results in increased expression of BAK1 protein] CTD PMID:14505808 BAK1 Human hyperforin increases expression EXP 6480464 hyperforin results in increased expression of BAK1 protein CTD PMID:32485087 BAK1 Human indometacin increases expression EXP 6480464 Indomethacin results in increased expression of BAK1 protein CTD PMID:11532860 BAK1 Human indometacin multiple interactions ISO Bak1 (Rattus norvegicus) 6480464 Melatonin inhibits the reaction [Indomethacin results in increased expression of BAK1 mRNA] CTD PMID:19220725 BAK1 Human indometacin increases expression ISO Bak1 (Rattus norvegicus) 6480464 Indomethacin results in increased expression of BAK1 mRNA CTD PMID:19220725 BAK1 Human inulin multiple interactions ISO Bak1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of BAK1 mRNA CTD PMID:36331819 BAK1 Human iohexol increases expression EXP 6480464 Iohexol results in increased expression of BAK1 mRNA CTD PMID:29705293 BAK1 Human iopamidol increases expression EXP 6480464 Iopamidol results in increased expression of BAK1 mRNA CTD PMID:29705293 BAK1 Human isoflurane decreases expression ISO Bak1 (Rattus norvegicus) 6480464 Isoflurane results in decreased expression of BAK1 mRNA CTD PMID:16978161 BAK1 Human isoprenaline decreases expression EXP 6480464 Isoproterenol results in decreased expression of BAK1 mRNA CTD PMID:24286936 BAK1 Human ivermectin decreases expression EXP 6480464 Ivermectin results in decreased expression of BAK1 protein CTD PMID:32959892 BAK1 Human L-ascorbic acid multiple interactions EXP 6480464 [arsenic trioxide co-treated with Ascorbic Acid co-treated with Disulfiram] results in decreased expression of BAK1 protein CTD PMID:24126434 BAK1 Human lead diacetate multiple interactions EXP 6480464 [[amyloid beta-protein (1-40) co-treated with amyloid beta-protein (25-35)] co-treated with [lead acetate results in increased abundance of Lead]] results in increased expression of BAK1 protein more ... CTD PMID:35300571 BAK1 Human lead(0) multiple interactions EXP 6480464 [[amyloid beta-protein (1-40) co-treated with amyloid beta-protein (25-35)] co-treated with [lead acetate results in increased abundance of Lead]] results in increased expression of BAK1 protein more ... CTD PMID:35300571 BAK1 Human levamisole increases expression EXP 6480464 Levamisole results in increased expression of BAK1 protein CTD PMID:11139434 BAK1 Human LGK974 multiple interactions EXP 6480464 LGK974 inhibits the reaction [Paraquat results in increased expression of BAK1 protein] CTD PMID:30205152 BAK1 Human Licochalcone A increases expression EXP 6480464 licochalcone A results in increased expression of BAK1 mRNA CTD PMID:30055311 BAK1 Human linalool increases expression EXP 6480464 linalool results in increased expression of BAK1 mRNA CTD PMID:28567457 BAK1 Human lithocholic acid multiple interactions ISO Bak1 (Mus musculus) 6480464 [Lithocholic Acid co-treated with 1 more ... CTD PMID:19433268 BAK1 Human losartan multiple interactions ISO Bak1 (Rattus norvegicus) 6480464 Losartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BAK1 mRNA] CTD PMID:15502641 BAK1 Human Luteolin 7-methyl ether increases expression ISO Bak1 (Rattus norvegicus) 6480464 hydroxygenkwanin results in increased expression of BAK1 protein CTD PMID:24144774 BAK1 Human lycopene multiple interactions ISO Bak1 (Mus musculus) 6480464 Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of BAK1 protein] CTD PMID:36583613 BAK1 Human Maduramicin increases expression ISO Bak1 (Mus musculus) 6480464 maduramicin results in increased expression of BAK1 protein CTD PMID:31229567 BAK1 Human maneb increases expression EXP 6480464 Maneb results in increased expression of BAK1 mRNA and Maneb results in increased expression of BAK1 protein CTD PMID:18266926 BAK1 Human maneb affects response to substance EXP 6480464 BAK1 protein affects the susceptibility to Maneb CTD PMID:18266926 BAK1 Human maneb multiple interactions EXP 6480464 [Paraquat co-treated with Maneb] results in increased expression of BAK1 protein more ... CTD PMID:18266926 BAK1 Human maneb multiple interactions ISO Bak1 (Mus musculus) 6480464 [Maneb co-treated with Paraquat] results in increased expression of BAK1 mRNA more ... CTD PMID:23963992 BAK1 Human mechlorethamine increases expression EXP 6480464 Mechlorethamine results in increased expression of BAK1 protein CTD PMID:22285227 BAK1 Human melatonin multiple interactions EXP 6480464 [Melatonin co-treated with Tretinoin] results in increased expression of BAK1 protein and Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BAK1 mRNA] CTD PMID:10965999 and PMID:33962019 BAK1 Human melatonin multiple interactions ISO Bak1 (Mus musculus) 6480464 Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of BAK1 mRNA] CTD PMID:23963992 BAK1 Human melatonin multiple interactions ISO Bak1 (Rattus norvegicus) 6480464 Melatonin inhibits the reaction [Indomethacin results in increased expression of BAK1 mRNA] CTD PMID:19220725 BAK1 Human melittin increases expression EXP 6480464 Melitten results in increased expression of BAK1 protein CTD PMID:34375656 BAK1 Human melphalan increases expression EXP 6480464 Melphalan results in increased expression of BAK1 protein CTD PMID:22285227 BAK1 Human menadione affects expression EXP 6480464 Vitamin K 3 affects the expression of BAK1 mRNA CTD PMID:20044591 BAK1 Human methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of BAK1 protein CTD PMID:23820845 BAK1 Human methamphetamine multiple interactions EXP 6480464 [N-Methyl-3 and 4-methylenedioxyamphetamine co-treated with Methamphetamine co-treated with 4-methylthioamphetamine co-treated with Dextroamphetamine] results in increased expression of BAK1 protein CTD PMID:23820845 BAK1 Human methotrexate increases expression EXP 6480464 Methotrexate results in increased expression of BAK1 mRNA CTD PMID:21678067 BAK1 Human methoxyacetic acid affects expression ISO Bak1 (Rattus norvegicus) 6480464 methoxyacetic acid affects the expression of BAK1 protein CTD PMID:10809232 BAK1 Human methyl methanesulfonate increases expression EXP 6480464 Methyl Methanesulfonate results in increased expression of BAK1 mRNA CTD PMID:23649840 and PMID:30581319 BAK1 Human methyl methanesulfonate multiple interactions EXP 6480464 Folic Acid inhibits the reaction [Methyl Methanesulfonate results in increased expression of BAK1 mRNA] CTD PMID:30581319 BAK1 Human minocycline multiple interactions ISO Bak1 (Rattus norvegicus) 6480464 [Minocycline results in increased expression of BCL2 protein] which binds to BAK1 protein CTD PMID:15004018 BAK1 Human Mitotane increases expression ISO Bak1 (Rattus norvegicus) 6480464 Mitotane results in increased expression of BAK1 mRNA CTD PMID:23485034 BAK1 Human MK-2206 multiple interactions EXP 6480464 [mirdametinib co-treated with MK 2206] results in increased expression of BAK1 protein more ... CTD PMID:27634878 BAK1 Human morphine increases expression EXP 6480464 Morphine results in increased expression of BAK1 protein CTD PMID:19070643 BAK1 Human mycophenolic acid increases expression EXP 6480464 Mycophenolic Acid results in increased expression of BAK1 protein CTD PMID:16505121 BAK1 Human Myrtucommulone A decreases expression ISO Bak1 (Mus musculus) 6480464 myrtucommulone A results in decreased expression of BAK1 mRNA CTD PMID:26032814 BAK1 Human N-acetyl-L-cysteine multiple interactions ISO Bak1 (Mus musculus) 6480464 Acetylcysteine inhibits the reaction [arsenic trioxide results in increased expression of BAK1 mRNA] and Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased expression of BAK1 mRNA] CTD PMID:21533816 and PMID:21549813 BAK1 Human N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Cadmium results in increased expression of BAK1] CTD PMID:23339468 BAK1 Human N-acetyl-L-cysteine multiple interactions ISO Bak1 (Rattus norvegicus) 6480464 Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased expression of BAK1 mRNA] more ... CTD PMID:22085843 and PMID:28296042 BAK1 Human N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases ubiquitination EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of BAK1 protein CTD PMID:36346691 BAK1 Human N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of BAK1 mRNA and 1-Methyl-4-phenylpyridinium results in increased expression of BAK1 protein CTD PMID:18266926 and PMID:27957685 BAK1 Human N-methyl-4-phenylpyridinium multiple interactions EXP 6480464 Flufenamic Acid inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAK1 protein] and TRPM2 protein promotes the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAK1 protein] CTD PMID:27957685 BAK1 Human N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions EXP 6480464 BAK1 protein results in increased susceptibility to [Methylnitronitrosoguanidine co-treated with veliparib] CTD PMID:18376143 BAK1 Human N-nitrosodiethylamine multiple interactions ISO Bak1 (Rattus norvegicus) 6480464 3 more ... CTD PMID:27048571 BAK1 Human navitoclax multiple interactions EXP 6480464 [navitoclax co-treated with Vorinostat] affects the activity of BAK1 protein CTD PMID:21652541 BAK1 Human nickel atom increases expression EXP 6480464 Nickel results in increased expression of BAK1 mRNA CTD PMID:24768652 and PMID:25583101 BAK1 Human nickel dichloride increases expression ISO Bak1 (Rattus norvegicus) 6480464 nickel chloride results in increased expression of BAK1 mRNA CTD PMID:21843586 BAK1 Human nickel dichloride affects expression ISO Bak1 (Rattus norvegicus) 6480464 nickel chloride affects the expression of BAK1 mRNA CTD PMID:22546817 BAK1 Human nickel sulfate multiple interactions ISO Bak1 (Rattus norvegicus) 6480464 Acetylcysteine inhibits the reaction [nickel sulfate results in increased expression of BAK1 mRNA] more ... CTD PMID:28296042 BAK1 Human nickel sulfate increases expression ISO Bak1 (Rattus norvegicus) 6480464 nickel sulfate results in increased expression of BAK1 mRNA and nickel sulfate results in increased expression of BAK1 protein CTD PMID:28296042 BAK1 Human niclosamide multiple interactions EXP 6480464 [Niclosamide binds to Polyethyleneimine] which results in increased expression of BAK1 mRNA CTD PMID:25988281 BAK1 Human nimesulide multiple interactions EXP 6480464 nimesulide inhibits the reaction [Etoposide results in increased activity of BAK1 protein] CTD PMID:21745461 BAK1 Human nimesulide decreases response to substance ISO Bak1 (Rattus norvegicus) 6480464 BAK1 results in decreased susceptibility to nimesulide CTD PMID:18349538 BAK1 Human NORCANTHARIDIN increases expression EXP 6480464 norcantharidin results in increased expression of BAK1 protein alternative form CTD PMID:29193574 BAK1 Human Nutlin-3 multiple interactions EXP 6480464 [nutlin 3 co-treated with Bortezomib] results in increased activity of BAK1 protein CTD PMID:20850924 BAK1 Human ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of BAK1 mRNA and ochratoxin A results in decreased expression of BAK1 protein CTD PMID:19367635 and PMID:30428381 BAK1 Human ochratoxin A multiple interactions EXP 6480464 [Citrinin co-treated with ochratoxin A] results in decreased expression of BAK1 mRNA CTD PMID:30428381 BAK1 Human ochratoxin A increases expression ISO Bak1 (Rattus norvegicus) 6480464 ochratoxin A results in increased expression of BAK1 mRNA CTD PMID:23358140 BAK1 Human okadaic acid increases expression EXP 6480464 Okadaic Acid results in increased expression of BAK1 mRNA CTD PMID:31926150 BAK1 Human omacetaxine mepesuccinate decreases expression EXP 6480464 Homoharringtonine results in decreased expression of BAK1 mRNA CTD PMID:32431164 BAK1 Human osthole increases expression EXP 6480464 osthol results in increased expression of BAK1 protein CTD PMID:29319219 BAK1 Human oxybenzone increases expression ISO Bak1 (Rattus norvegicus) 6480464 oxybenzone results in increased expression of BAK1 mRNA and oxybenzone results in increased expression of BAK1 protein CTD PMID:30099065 and PMID:30316929 BAK1 Human ozone multiple interactions ISO Bak1 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of BAK1 mRNA CTD PMID:34911549 BAK1 Human p-menthan-3-ol increases expression EXP 6480464 Menthol results in increased expression of BAK1 mRNA CTD PMID:26760959 BAK1 Human paclitaxel affects expression EXP 6480464 Paclitaxel affects the expression of BAK1 mRNA and Paclitaxel affects the expression of BAK1 protein CTD PMID:10822281 BAK1 Human paclitaxel increases expression EXP 6480464 Paclitaxel results in increased expression of BAK1 mRNA and Paclitaxel results in increased expression of BAK1 protein CTD PMID:10822281 and PMID:24126434 BAK1 Human paclitaxel multiple interactions ISO Bak1 (Mus musculus) 6480464 [BAK1 protein mutant form co-treated with BAX protein mutant form] inhibits the reaction [Paclitaxel results in increased activity of and results in increased cleavage of CASP3 protein] CTD PMID:17652622 BAK1 Human paclitaxel increases response to substance EXP 6480464 BAK1 protein results in increased susceptibility to Paclitaxel CTD PMID:17688235 BAK1 Human paracetamol affects expression ISO Bak1 (Mus musculus) 6480464 Acetaminophen affects the expression of BAK1 mRNA CTD PMID:17562736 BAK1 Human paracetamol decreases expression ISO Bak1 (Rattus norvegicus) 6480464 Acetaminophen results in decreased expression of BAK1 mRNA CTD PMID:33387578 BAK1 Human paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of BAK1 mRNA CTD PMID:27761495 BAK1 Human paracetamol multiple interactions ISO Bak1 (Mus musculus) 6480464 dioscin inhibits the reaction [Acetaminophen results in increased expression of BAK1 protein] CTD PMID:22939915 BAK1 Human paracetamol increases expression ISO Bak1 (Mus musculus) 6480464 Acetaminophen results in increased expression of BAK1 protein CTD PMID:22939915 BAK1 Human paraquat increases expression EXP 6480464 Paraquat results in increased expression of BAK1 mRNA and Paraquat results in increased expression of BAK1 protein CTD PMID:18056701 more ... BAK1 Human paraquat affects response to substance ISO Bak1 (Mus musculus) 6480464 BAK1 protein affects the susceptibility to Paraquat CTD PMID:33900547 BAK1 Human paraquat affects response to substance EXP 6480464 BAK1 protein affects the susceptibility to Paraquat CTD PMID:18056701 and PMID:18266926 BAK1 Human paraquat multiple interactions EXP 6480464 [Paraquat co-treated with Maneb] results in increased expression of BAK1 protein more ... CTD PMID:18266926 and PMID:30205152 BAK1 Human paraquat multiple interactions ISO Bak1 (Mus musculus) 6480464 [Maneb co-treated with Paraquat] results in increased expression of BAK1 mRNA more ... CTD PMID:23963992 BAK1 Human paraquat increases expression ISO Bak1 (Mus musculus) 6480464 Paraquat results in increased expression of BAK1 protein CTD PMID:18056701 BAK1 Human paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of BAK1 mRNA CTD PMID:18836921 BAK1 Human paraquat multiple interactions ISO Bak1 (Rattus norvegicus) 6480464 NFE2L2 mutant form inhibits the reaction [Paraquat results in increased expression of BAK1 mRNA] and Paraquat promotes the reaction [BAX protein binds to BAK1 protein] CTD PMID:22678742 and PMID:25947082 BAK1 Human paraquat increases expression ISO Bak1 (Rattus norvegicus) 6480464 Paraquat results in increased expression of BAK1 mRNA and Paraquat results in increased expression of BAK1 protein CTD PMID:22678742 BAK1 Human parathion increases methylation EXP 6480464 Parathion results in increased methylation of BAK1 promoter CTD PMID:22847954 BAK1 Human parthenolide increases expression EXP 6480464 parthenolide results in increased expression of BAK1 protein CTD PMID:16024633 BAK1 Human PD 0325901 increases expression EXP 6480464 mirdametinib results in increased expression of BAK1 protein CTD PMID:27634878 BAK1 Human PD 0325901 multiple interactions EXP 6480464 [mirdametinib co-treated with MK 2206] results in increased expression of BAK1 protein more ... CTD PMID:27634878 BAK1 Human perfluorohexanesulfonic acid decreases expression ISO Bak1 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in decreased expression of BAK1 mRNA CTD PMID:37995155 BAK1 Human perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of BAK1 mRNA CTD PMID:32790152 BAK1 Human perfluorooctane-1-sulfonic acid multiple interactions ISO Bak1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of BAK1 mRNA more ... CTD PMID:36331819 BAK1 Human perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 perfluorooctane sulfonic acid promotes the reaction [BAX protein binds to BAK1 protein] CTD PMID:34006824 BAK1 Human perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of BAK1 mRNA CTD PMID:32790152 BAK1 Human perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of BAK1 protein CTD PMID:35123991 BAK1 Human perifosine multiple interactions EXP 6480464 [perifosine co-treated with Butyrates] results in decreased expression of BAK1 protein more ... CTD PMID:15781658 BAK1 Human perillyl alcohol increases expression EXP 6480464 perillyl alcohol results in increased expression of BAK1 protein CTD PMID:12530055 BAK1 Human PF-3758309 increases expression EXP 6480464 PF 3758309 results in increased expression of BAK1 mRNA and PF 3758309 results in increased expression of BAK1 protein CTD PMID:29048629 BAK1 Human phenobarbital multiple interactions ISO Bak1 (Mus musculus) 6480464 [Lithocholic Acid co-treated with Phenobarbital] results in decreased expression of BAK1 protein CTD PMID:19433268 BAK1 Human phenobarbital multiple interactions ISO Bak1 (Rattus norvegicus) 6480464 3 more ... CTD PMID:27048571 BAK1 Human phorbol 13-acetate 12-myristate increases expression EXP 6480464 Tetradecanoylphorbol Acetate results in increased expression of BAK1 protein CTD PMID:11139146 BAK1 Human pifithrin-alpha hydrobromide multiple interactions ISO Bak1 (Rattus norvegicus) 6480464 pifithrin inhibits the reaction [triptolide results in increased expression of BAK1 protein] CTD PMID:30009776 BAK1 Human pinostrobin increases expression EXP 6480464 pinostrobin results in increased expression of BAK1 mRNA CTD PMID:37164308 BAK1 Human platycodin D increases expression EXP 6480464 platycodin D results in increased expression of BAK1 protein CTD PMID:23236765 BAK1 Human pregnenolone 16alpha-carbonitrile multiple interactions ISO Bak1 (Mus musculus) 6480464 [Lithocholic Acid co-treated with Pregnenolone Carbonitrile] results in decreased expression of BAK1 protein CTD PMID:19433268 BAK1 Human promethazine increases expression EXP 6480464 Promethazine results in increased expression of BAK1 protein CTD PMID:31682805 BAK1 Human propylparaben increases expression EXP 6480464 propylparaben results in increased expression of BAK1 mRNA CTD PMID:24481588 BAK1 Human prostaglandin E2 multiple interactions ISO Bak1 (Mus musculus) 6480464 Dinoprostone inhibits the reaction [PTGS1 gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of BAK1 protein]] CTD PMID:25432964 BAK1 Human pterostilbene increases expression EXP 6480464 pterostilbene results in increased expression of BAK1 protein CTD PMID:23313376 BAK1 Human pyrethrins decreases expression EXP 6480464 Pyrethrins results in decreased expression of BAK1 mRNA CTD PMID:35321623 BAK1 Human pyrrolidine dithiocarbamate multiple interactions ISO Bak1 (Rattus norvegicus) 6480464 [Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased expression of BAK1 mRNA more ... CTD PMID:22085843 BAK1 Human quercetin multiple interactions ISO Bak1 (Rattus norvegicus) 6480464 Quercetin inhibits the reaction [Hydrogen Peroxide results in increased expression of BAK1 protein] CTD PMID:14505808 BAK1 Human quercetin increases expression EXP 6480464 Quercetin metabolite results in increased expression of BAK1 protein and Quercetin results in increased expression of BAK1 protein CTD PMID:16280456 more ... BAK1 Human quercetin increases expression ISO Bak1 (Mus musculus) 6480464 Quercetin results in increased expression of BAK1 protein CTD PMID:17039455 BAK1 Human raloxifene decreases expression EXP 6480464 Raloxifene Hydrochloride results in decreased expression of BAK1 mRNA CTD PMID:16202921 BAK1 Human resveratrol multiple interactions EXP 6480464 [benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] inhibits the reaction [resveratrol results in increased localization of BAK1 protein] more ... CTD PMID:12902349 more ... BAK1 Human resveratrol multiple interactions ISO Bak1 (Mus musculus) 6480464 Resveratrol results in increased expression of and results in increased localization of BAK1 protein CTD PMID:37482209 BAK1 Human resveratrol increases activity EXP 6480464 resveratrol results in increased activity of BAK1 protein CTD PMID:22245142 and PMID:22644961 BAK1 Human resveratrol increases response to substance EXP 6480464 BAK1 protein results in increased susceptibility to resveratrol CTD PMID:16550006 and PMID:22245142 BAK1 Human resveratrol increases expression EXP 6480464 resveratrol results in increased expression of BAK1 mRNA and resveratrol results in increased expression of BAK1 protein CTD PMID:12002526 more ... BAK1 Human resveratrol affects folding EXP 6480464 resveratrol affects the folding of BAK1 protein CTD PMID:16617056 BAK1 Human ritonavir increases expression EXP 6480464 Ritonavir results in increased expression of BAK1 protein CTD PMID:19386116 BAK1 Human romidepsin multiple interactions EXP 6480464 [romidepsin co-treated with mirdametinib co-treated with MK 2206] results in increased expression of BAK1 protein more ... CTD PMID:27634878 BAK1 Human romidepsin increases expression EXP 6480464 romidepsin results in increased expression of BAK1 protein CTD PMID:27634878 BAK1 Human rottlerin multiple interactions EXP 6480464 rottlerin inhibits the reaction [Doxorubicin results in increased activity of BAK1 protein] CTD PMID:15917298 BAK1 Human Salinomycin increases expression EXP 6480464 salinomycin results in increased expression of BAK1 mRNA CTD PMID:34806536 BAK1 Human SB 203580 multiple interactions EXP 6480464 SB 203580 inhibits the reaction [Sulindac affects the localization of BAK1 protein] CTD PMID:17136320 BAK1 Human Se-methyl-L-selenocysteine increases expression EXP 6480464 selenomethylselenocysteine metabolite results in increased expression of BAK1 mRNA CTD PMID:25321483 BAK1 Human Se-methylselenocysteine increases expression EXP 6480464 selenomethylselenocysteine metabolite results in increased expression of BAK1 mRNA CTD PMID:25321483 BAK1 Human sodium arsenite decreases expression ISO Bak1 (Mus musculus) 6480464 sodium arsenite results in decreased expression of BAK1 mRNA CTD PMID:16014739 BAK1 Human sorafenib multiple interactions EXP 6480464 [sorafenib co-treated with TNFSF10 protein] affects the folding of and results in increased activity of BAK1 protein more ... CTD PMID:17909059 and PMID:24434019 BAK1 Human sorafenib increases expression EXP 6480464 sorafenib results in increased expression of BAK1 protein CTD PMID:18200035 BAK1 Human sorafenib decreases expression EXP 6480464 sorafenib results in decreased expression of BAK1 protein CTD PMID:16109713 BAK1 Human streptozocin increases expression ISO Bak1 (Rattus norvegicus) 6480464 Streptozocin results in increased expression of BAK1 protein CTD PMID:28856781 BAK1 Human streptozocin multiple interactions ISO Bak1 (Rattus norvegicus) 6480464 Anthocyanins inhibits the reaction [Streptozocin results in increased expression of BAK1 protein] CTD PMID:28856781 BAK1 Human succimer multiple interactions ISO Bak1 (Mus musculus) 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BAK1 mRNA CTD PMID:26378955 BAK1 Human sulindac affects localization EXP 6480464 Sulindac affects the localization of BAK1 protein CTD PMID:17136320 BAK1 Human sulindac multiple interactions EXP 6480464 SB 203580 inhibits the reaction [Sulindac affects the localization of BAK1 protein] CTD PMID:17136320 BAK1 Human sulindac sulfide increases response to substance ISO Bak1 (Rattus norvegicus) 6480464 BAK1 results in increased susceptibility to sulindac sulfide CTD PMID:18349538 BAK1 Human sulindac sulfone increases response to substance ISO Bak1 (Rattus norvegicus) 6480464 BAK1 results in increased susceptibility to sulindac sulfone CTD PMID:18349538 BAK1 Human surfactin increases expression EXP 6480464 surfactin peptide results in increased expression of BAK1 protein CTD PMID:34850538 BAK1 Human surfactin C increases expression EXP 6480464 surfactin peptide results in increased expression of BAK1 protein CTD PMID:34850538 BAK1 Human T-2 toxin increases expression EXP 6480464 T-2 Toxin results in increased expression of BAK1 mRNA CTD PMID:34581912 BAK1 Human taiwanin C increases expression ISO Bak1 (Mus musculus) 6480464 taiwanin C results in increased expression of BAK1 protein CTD PMID:30884126 BAK1 Human tamibarotene increases expression EXP 6480464 tamibarotene results in increased expression of BAK1 mRNA CTD PMID:15498508 BAK1 Human TEMPO multiple interactions ISO Bak1 (Rattus norvegicus) 6480464 TEMPO inhibits the reaction [nickel sulfate results in increased expression of BAK1 mRNA] and TEMPO inhibits the reaction [nickel sulfate results in increased expression of BAK1 protein] CTD PMID:28296042 BAK1 Human terbufos increases methylation EXP 6480464 terbufos results in increased methylation of BAK1 promoter CTD PMID:22847954 BAK1 Human tert-butyl hydroperoxide decreases expression EXP 6480464 tert-Butylhydroperoxide results in decreased expression of BAK1 mRNA CTD PMID:12419474 BAK1 Human tetrachloromethane multiple interactions ISO Bak1 (Rattus norvegicus) 6480464 [Ethanol co-treated with pyrazole co-treated with Carbon Tetrachloride] results in increased expression of BAK1 mRNA CTD PMID:16610055 BAK1 Human tetrachloromethane increases expression ISO Bak1 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of BAK1 protein CTD PMID:23279844 and PMID:25432964 BAK1 Human tetrachloromethane multiple interactions ISO Bak1 (Mus musculus) 6480464 Dinoprostone inhibits the reaction [PTGS1 gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of BAK1 protein]] more ... CTD PMID:23279844 and PMID:25432964 BAK1 Human thioacetamide increases expression ISO Bak1 (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of BAK1 mRNA CTD PMID:23411599 and PMID:34492290 BAK1 Human Thiotepa affects expression EXP 6480464 Thiotepa affects the expression of BAK1 protein CTD PMID:10822281 BAK1 Human Thiotepa increases expression EXP 6480464 Thiotepa results in increased expression of BAK1 protein CTD PMID:10822281 BAK1 Human trichostatin A multiple interactions EXP 6480464 [perifosine co-treated with trichostatin A] results in decreased expression of BAK1 protein CTD PMID:15781658 BAK1 Human trichostatin A decreases expression ISO Bak1 (Rattus norvegicus) 6480464 trichostatin A results in decreased expression of BAK1 mRNA CTD PMID:23558232 BAK1 Human trimellitic anhydride increases expression ISO Bak1 (Mus musculus) 6480464 trimellitic anhydride results in increased expression of BAK1 mRNA CTD PMID:19042947 BAK1 Human triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of BAK1 mRNA CTD PMID:37042841 BAK1 Human Triptolide increases expression ISO Bak1 (Rattus norvegicus) 6480464 triptolide results in increased expression of BAK1 protein CTD PMID:30009776 BAK1 Human Triptolide multiple interactions ISO Bak1 (Mus musculus) 6480464 TRP53 gene mutant form inhibits the reaction [triptolide results in increased expression of BAK1 protein] CTD PMID:30009776 BAK1 Human Triptolide multiple interactions ISO Bak1 (Rattus norvegicus) 6480464 pifithrin inhibits the reaction [triptolide results in increased expression of BAK1 protein] CTD PMID:30009776 BAK1 Human Triptolide increases expression ISO Bak1 (Mus musculus) 6480464 triptolide results in increased expression of BAK1 protein CTD PMID:30009776 BAK1 Human tunicamycin increases activity EXP 6480464 Tunicamycin results in increased activity of BAK1 protein CTD PMID:17553788 BAK1 Human urethane multiple interactions ISO Bak1 (Mus musculus) 6480464 [Urethane co-treated with Freund's Adjuvant] results in increased expression of BAK1 mRNA CTD PMID:12400877 BAK1 Human urethane increases expression EXP 6480464 Urethane results in increased expression of BAK1 mRNA CTD PMID:28818685 BAK1 Human ursolic acid increases activity EXP 6480464 Ursolic Acid results in increased activity of BAK1 protein CTD PMID:20630652 BAK1 Human usnic acid increases expression EXP 6480464 usnic acid results in increased expression of BAK1 mRNA CTD PMID:32508146 BAK1 Human valproic acid increases expression ISO Bak1 (Mus musculus) 6480464 Valproic Acid results in increased expression of BAK1 mRNA CTD PMID:21427059 BAK1 Human valproic acid increases methylation ISO Bak1 (Rattus norvegicus) 6480464 Valproic Acid results in increased methylation of BAK1 promoter CTD PMID:33150595 BAK1 Human valproic acid decreases expression ISO Bak1 (Rattus norvegicus) 6480464 Valproic Acid results in decreased expression of BAK1 mRNA CTD PMID:33150595 BAK1 Human valproic acid decreases expression ISO Bak1 (Mus musculus) 6480464 Valproic Acid results in decreased expression of BAK1 mRNA CTD PMID:21427059 BAK1 Human veliparib multiple interactions EXP 6480464 BAK1 protein results in increased susceptibility to [Methylnitronitrosoguanidine co-treated with veliparib] CTD PMID:18376143 BAK1 Human venetoclax affects folding EXP 6480464 venetoclax affects the folding of BAK1 protein CTD PMID:30647404 BAK1 Human vincristine affects response to substance EXP 6480464 BAK1 protein affects the susceptibility to Vincristine CTD PMID:22178383 BAK1 Human vorinostat multiple interactions EXP 6480464 [navitoclax co-treated with Vorinostat] affects the activity of BAK1 protein more ... CTD PMID:15781658 more ... BAK1 Human vorinostat increases expression EXP 6480464 vorinostat results in increased expression of BAK1 mRNA and vorinostat results in increased expression of BAK1 protein CTD PMID:16144943 and PMID:19509267 BAK1 Human vorinostat affects activity EXP 6480464 vorinostat affects the activity of BAK1 protein CTD PMID:21652541 BAK1 Human xanthohumol increases expression EXP 6480464 xanthohumol results in increased expression of BAK1 protein CTD PMID:35229981